Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$58,981,440
+$976,414 QoQ
Shares Held
210,648
-3.1% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#64
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $1,383,676,421 across 25 Diagnostics & Research names. LH ranks #9 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,079,578 | $276,230,345 | |
| 2 | ILMN |
Illumina, Inc.
|
907,489 | $159,563,790 | |
| 3 | NEO |
Neogenomics Inc
|
10,113,261 | $147,552,477 | |
| 4 | VCYT |
Veracyte, Inc.
|
2,507,902 | $147,289,084 | |
| 5 | NTRA |
Natera, Inc.
|
511,214 | $138,769,040 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
202,754 | $106,737,815 | |
| 7 | WAT |
Waters Corp /De/
|
272,470 | $102,187,148 | |
| 8 | DGX |
Quest Diagnostics Inc
|
290,970 | $61,671,091 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $58,981,440 | 210,648 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $58,005,026 | 217,402 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $48,368,911 | 192,797 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $54,035,026 | 188,236 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $22,587,935 | 86,046 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,929,237 | 46,959 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $15,924,210 | 69,441 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $11,567,101 | 51,759 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,342,737 | 45,908 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||